甲基化物通过多巴胺基调节来重组皮质层次结构
Dardo Tomasi1, Peter Manza2,3, Şükrü Barış Demiral2
1National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA. dardo.tomasi@nih.gov.
Nature communications
|December 13, 2025
概括
甲基化物 (MP) 压缩大脑的功能层次,改变神经通信. 这种由多巴胺驱动的重组与改善的注意力和受体可用性的个体差异有关.
科学领域:
- 神经科学是一个神经科学.
- 认知神经科学 认知神经科学
- 神经成像是一种神经成像.
背景情况:
- 多巴氨基信号影响大脑网络架构沿着一个传感运动到关联皮质梯度.
- 增强多巴胺的精神兴奋剂,如甲基 (MP) 对这种功能层次和注意力的影响仍然不清楚.
研究的目的:
- 调查甲基化物 (MP) 如何影响人类大脑的主要功能梯度.
- 确定MP诱导的皮质组织变化是否与注意力和多巴胺受体的可用性有关.
主要方法:
- 在MP给药后使用PET和fMRI对健康成年人 (n=38,n=20) 进行了两项双盲,安慰剂控制的研究.
- 在青少年大脑认知发展 (ABCD) 研究中的大型独立队列中的验证 (n=4,958).
主要成果:
- 甲基化物 (MP) 始终压缩了主要的功能梯度,减少了感觉皮层和关联皮层之间的分离.
- 梯度压缩的程度与个体条纹D1和D2受体的可用性相关.
- 在下皮质中MP诱导的渐变压缩与注意力改善有关.
结论:
- 多巴胺敏感机制是皮质功能重组的基础,支持认知表现.
- 甲基化物 (MP) 改变大规模的大脑网络组织,通过渐变压缩机制影响注意力.
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Attention-Deficit/Hyperactivity Disorder
709
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
709
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
724
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
724
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K


